Kailera Therapeutics Inc.
KLRA | NASDAQ
$12.29
-$0.57 (-4.43%)
Nov 2, 2026, 10:57 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
PE Ratio | -12.52 | -38.81 |
PEG Ratio | -0.20 | n/a |
PS Ratio | n/a | n/a |
PB Ratio | 2.01 | -7.10 |
P/FCF Ratio | -15.44 | -44.89 |
P/OCF Ratio | -15.44 | -44.89 |
OCF/S Ratio | n/a | n/a |
Debt / Equity Ratio | 0.01 | -0.02 |
Quick Ratio | 11.11 | 9.67 |
Current Ratio | 11.11 | 9.67 |
Asset Turnover | n/a | n/a |
Interest Coverage | n/a | n/a |
Return on Equity | -9.95% | 18.25% |
Return on Assets | -9.19% | -12.62% |
Return on Invested Capital | -10.75% | -14.83% |
Dividend Yield | n/a | n/a |
Payout Ratio | n/a | n/a |
FCF Payout Ratio | n/a | n/a |
Gross Profit Margin | n/a | n/a |
Net Profit Margin | n/a | n/a |
Pretax Profit Margin | n/a | n/a |
Operating Profit Margin | n/a | n/a |
FCF Margin | n/a | n/a |
EBITDA Margin | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove KLRA